In this study, we found that RSPO4 inhibited tumor cell proliferation, metastasis and stemness through suppressing both canonical and non-canonical Wnt/β-catenin signaling, indicating RSPO4 as a Wnt antagonist. Here, RSPO4 is linked to neoplasm.